NO144925C - Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonatInfo
- Publication number
- NO144925C NO144925C NO761367A NO761367A NO144925C NO 144925 C NO144925 C NO 144925C NO 761367 A NO761367 A NO 761367A NO 761367 A NO761367 A NO 761367A NO 144925 C NO144925 C NO 144925C
- Authority
- NO
- Norway
- Prior art keywords
- disulphonate
- mercaptomethyl
- pyridinium
- ethane
- hydroxymethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
- C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57605575A | 1975-05-09 | 1975-05-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO761367L NO761367L (xx) | 1976-11-10 |
| NO144925B NO144925B (no) | 1981-08-31 |
| NO144925C true NO144925C (no) | 1981-12-09 |
Family
ID=24302783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO761367A NO144925C (no) | 1975-05-09 | 1976-04-22 | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-5-mercaptomethyl-pyridinium)-ethan-1,2-disulfonat |
Country Status (29)
| Country | Link |
|---|---|
| JP (1) | JPS51138684A (xx) |
| AR (1) | AR210883A1 (xx) |
| AT (1) | AT348691B (xx) |
| AU (1) | AU1342876A (xx) |
| BE (1) | BE841593A (xx) |
| BG (1) | BG25218A3 (xx) |
| CA (1) | CA1088542A (xx) |
| CH (1) | CH625222A5 (xx) |
| CS (1) | CS189003B2 (xx) |
| DD (1) | DD125482A5 (xx) |
| DE (1) | DE2620325C3 (xx) |
| DK (1) | DK143335C (xx) |
| ES (1) | ES447717A1 (xx) |
| FI (1) | FI61881C (xx) |
| FR (1) | FR2310130A1 (xx) |
| GB (1) | GB1490688A (xx) |
| GR (1) | GR59817B (xx) |
| HU (1) | HU172048B (xx) |
| IE (1) | IE43030B1 (xx) |
| IL (1) | IL49466A (xx) |
| LU (1) | LU74892A1 (xx) |
| NL (1) | NL7604285A (xx) |
| NO (1) | NO144925C (xx) |
| NZ (1) | NZ180691A (xx) |
| PL (1) | PL100306B1 (xx) |
| PT (1) | PT65061B (xx) |
| RO (1) | RO68526A (xx) |
| SE (1) | SE427033B (xx) |
| ZA (1) | ZA762750B (xx) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1695428C3 (de) * | 1967-06-08 | 1978-10-05 | Merck Patent Gmbh, 6100 Darmstadt | Derivate des 5-Mercaptopyridoxins und Verfahren zu deren Herstellung |
| US3852454A (en) * | 1973-06-15 | 1974-12-03 | Merck & Co Inc | Treatment of rheumatoid arthritis |
-
1976
- 1976-04-21 FI FI761084A patent/FI61881C/fi not_active IP Right Cessation
- 1976-04-21 SE SE7604580A patent/SE427033B/xx not_active IP Right Cessation
- 1976-04-21 DK DK179376A patent/DK143335C/da not_active IP Right Cessation
- 1976-04-22 NL NL7604285A patent/NL7604285A/xx not_active Application Discontinuation
- 1976-04-22 NO NO761367A patent/NO144925C/no unknown
- 1976-04-24 RO RO7685792A patent/RO68526A/ro unknown
- 1976-04-26 IL IL49466A patent/IL49466A/xx unknown
- 1976-04-26 CH CH521976A patent/CH625222A5/de not_active IP Right Cessation
- 1976-04-26 NZ NZ180691A patent/NZ180691A/xx unknown
- 1976-04-27 AR AR263046A patent/AR210883A1/es active
- 1976-04-28 AU AU13428/76A patent/AU1342876A/en not_active Expired
- 1976-04-29 GR GR50620A patent/GR59817B/el unknown
- 1976-04-30 PT PT65061A patent/PT65061B/pt unknown
- 1976-05-04 GB GB18196/76A patent/GB1490688A/en not_active Expired
- 1976-05-04 CA CA251,741A patent/CA1088542A/en not_active Expired
- 1976-05-04 BG BG033100A patent/BG25218A3/xx unknown
- 1976-05-05 FR FR7613351A patent/FR2310130A1/fr active Granted
- 1976-05-06 DD DD192709A patent/DD125482A5/xx unknown
- 1976-05-06 PL PL1976189342A patent/PL100306B1/pl unknown
- 1976-05-06 LU LU74892A patent/LU74892A1/xx unknown
- 1976-05-07 BE BE166849A patent/BE841593A/xx unknown
- 1976-05-07 ZA ZA762750A patent/ZA762750B/xx unknown
- 1976-05-07 CS CS763063A patent/CS189003B2/cs unknown
- 1976-05-07 ES ES447717A patent/ES447717A1/es not_active Expired
- 1976-05-07 AT AT335676A patent/AT348691B/de not_active IP Right Cessation
- 1976-05-07 DE DE2620325A patent/DE2620325C3/de not_active Expired
- 1976-05-07 HU HU76ME00001974A patent/HU172048B/hu unknown
- 1976-05-07 IE IE990/76A patent/IE43030B1/en unknown
- 1976-05-08 JP JP51051720A patent/JPS51138684A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO152215C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 4,5-diaryl-2-nitroimidazoler | |
| NO166320C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater. | |
| NO145379C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider. | |
| NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
| NO146095C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater | |
| NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
| NO145198C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktivt 1,2-benzisotia-zolinon-3 | |
| NO152414C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2,6-dialkoksybenzamider | |
| NO146060C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol | |
| NO147150C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperidiner. | |
| NO144457C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydro-1,4-pyridiner | |
| NO151660C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater. | |
| NO145163C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive antitumorglykosider | |
| NO145620C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere. | |
| NO150158C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 6,7-dimetoksyquinazolinderivater | |
| NO146863C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive alkyltiofenoksyalkylaminer | |
| NO146777C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 6h-indolo (3,2,1-de)-(1,5)-naftyridinderivater | |
| NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater | |
| NO149960C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive bis(nitrosoureido)-polyolderivater | |
| NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
| NO154088C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive tetrahydrokinoliner. | |
| NO144149C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt bis-(2-methyl-3-hydroxy-4-hydroxymethyl-pyrid-5-yl-methyl)-carbodithioat | |
| NO152839C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater. | |
| NO144741C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopyrano-pyrazoler | |
| NO153221C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 6-metoksy-alfa-karboksypenicilliner. |